S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis

Objective. To analyse levels of S100A8/S100A9 (calprotectin) and selected cytokines, in blood, in patients with psoriatic arthritis (PsA). Methods. Sixty-five patients with PsA were examined for clinical manifestations and laboratory measurements of S-calprotectin, ESR, hs-CRP, and selected cytokine...

Full description

Saved in:
Bibliographic Details
Main Authors: Claes Hansson, Catharina Eriksson, Gerd-Marie Alenius
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2014/696415
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551744283869184
author Claes Hansson
Catharina Eriksson
Gerd-Marie Alenius
author_facet Claes Hansson
Catharina Eriksson
Gerd-Marie Alenius
author_sort Claes Hansson
collection DOAJ
description Objective. To analyse levels of S100A8/S100A9 (calprotectin) and selected cytokines, in blood, in patients with psoriatic arthritis (PsA). Methods. Sixty-five patients with PsA were examined for clinical manifestations and laboratory measurements of S-calprotectin, ESR, hs-CRP, and selected cytokines. Thirty-two patients had mono-/oligoarthritis and 33 had polyarthritis. S-calprotectin, hs-CRP, and cytokines were measured using ELISA, immunoturbidimetry, and multiplex technology (Bio-Plex). Patients with PsA were compared with 31 healthy controls. Results. S-calprotectin and hs-CRP levels were significantly higher in patients with PsA compared with controls (P<0.001 and P<0.001, resp.). Patients suffering a polyarthritic disease pattern presented with significantly higher levels of S-calprotectin compared with controls and patients with mono-/oligoarthritis (P<0.001 and P=0.017, resp.). The levels of S-calprotectin correlated with hs-CRP (P<0.001; rs=0.441), swollen joint count (P=0.002, rs=0.397), and CXCL10 (P=0.046, rs=0.678) but not with any of the other cytokines evaluated. In multiple logistic regression analysis, S-calprotectin was the only variable significantly associated with psoriatic arthritis (P=0.002, OR=1.006, 95% CI = 1.002–1.010). Conclusion. S-calprotectin and hs-CRP levels were significantly higher in patients with PsA. A polyarthritic disease pattern showed higher levels of S-calprotectin than mono-/oligoarthritis. S-calprotectin is considered a potential marker of disease activity in patients with PsA.
format Article
id doaj-art-85dd7df12f0d4935859b2ba09ade3f0d
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-85dd7df12f0d4935859b2ba09ade3f0d2025-02-03T06:00:35ZengWileyJournal of Immunology Research2314-88612314-71562014-01-01201410.1155/2014/696415696415S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic ArthritisClaes Hansson0Catharina Eriksson1Gerd-Marie Alenius2Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, 901 87 Umeå, SwedenDepartment of Clinical Microbiology/Clinical Immunology, Umeå University, 901 87 Umeå, SwedenDepartment of Public Health and Clinical Medicine/Rheumatology, Umeå University, 901 87 Umeå, SwedenObjective. To analyse levels of S100A8/S100A9 (calprotectin) and selected cytokines, in blood, in patients with psoriatic arthritis (PsA). Methods. Sixty-five patients with PsA were examined for clinical manifestations and laboratory measurements of S-calprotectin, ESR, hs-CRP, and selected cytokines. Thirty-two patients had mono-/oligoarthritis and 33 had polyarthritis. S-calprotectin, hs-CRP, and cytokines were measured using ELISA, immunoturbidimetry, and multiplex technology (Bio-Plex). Patients with PsA were compared with 31 healthy controls. Results. S-calprotectin and hs-CRP levels were significantly higher in patients with PsA compared with controls (P<0.001 and P<0.001, resp.). Patients suffering a polyarthritic disease pattern presented with significantly higher levels of S-calprotectin compared with controls and patients with mono-/oligoarthritis (P<0.001 and P=0.017, resp.). The levels of S-calprotectin correlated with hs-CRP (P<0.001; rs=0.441), swollen joint count (P=0.002, rs=0.397), and CXCL10 (P=0.046, rs=0.678) but not with any of the other cytokines evaluated. In multiple logistic regression analysis, S-calprotectin was the only variable significantly associated with psoriatic arthritis (P=0.002, OR=1.006, 95% CI = 1.002–1.010). Conclusion. S-calprotectin and hs-CRP levels were significantly higher in patients with PsA. A polyarthritic disease pattern showed higher levels of S-calprotectin than mono-/oligoarthritis. S-calprotectin is considered a potential marker of disease activity in patients with PsA.http://dx.doi.org/10.1155/2014/696415
spellingShingle Claes Hansson
Catharina Eriksson
Gerd-Marie Alenius
S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
Journal of Immunology Research
title S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
title_full S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
title_fullStr S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
title_full_unstemmed S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
title_short S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
title_sort s calprotectin s100a8 s100a9 a potential marker of inflammation in patients with psoriatic arthritis
url http://dx.doi.org/10.1155/2014/696415
work_keys_str_mv AT claeshansson scalprotectins100a8s100a9apotentialmarkerofinflammationinpatientswithpsoriaticarthritis
AT catharinaeriksson scalprotectins100a8s100a9apotentialmarkerofinflammationinpatientswithpsoriaticarthritis
AT gerdmariealenius scalprotectins100a8s100a9apotentialmarkerofinflammationinpatientswithpsoriaticarthritis